Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)
China · Delayed Price · Currency is CNY 12.21
-0.40 (-3.17%)
Jun 18, 2026, 3:04 PM CST
SHE:300122 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
| 29,228 | 45,171 | 62,957 | 146,664 | 140,528 | 199,360 | |
Market Cap Growth | -37.54% | -28.25% | -57.07% | 4.37% | -29.51% | -15.76% |
Enterprise Value | 39,084 | 57,047 | 68,773 | 148,099 | 139,912 | 195,638 |
Last Close Price | 12.21 | 18.87 | 26.30 | 58.88 | 56.01 | 79.02 |
PE Ratio | - | - | 31.92 | 18.17 | 18.64 | 19.53 |
Forward PE | 9.42 | - | 14.60 | 15.39 | 19.63 | 21.81 |
PS Ratio | 3.34 | 5.04 | 2.42 | 2.77 | 3.67 | 6.50 |
PB Ratio | 1.86 | 2.81 | 2.04 | 4.66 | 5.80 | 11.29 |
P/TBV Ratio | 1.97 | 2.96 | 2.07 | 4.71 | 5.89 | 11.53 |
P/FCF Ratio | 6.35 | 9.93 | - | 18.65 | 262.21 | 30.32 |
P/OCF Ratio | 5.72 | 8.74 | - | 16.30 | 70.65 | 23.43 |
PEG Ratio | - | - | - | 0.86 | 0.66 | 0.66 |
EV/Sales Ratio | 4.46 | 6.37 | 2.64 | 2.80 | 3.66 | 6.38 |
EV/EBITDA Ratio | - | - | 26.09 | 15.56 | 15.54 | 15.91 |
EV/EBIT Ratio | - | - | 30.49 | 16.09 | 16.09 | 16.41 |
EV/FCF Ratio | 8.50 | 12.54 | - | 18.84 | 261.06 | 29.75 |
Debt / Equity Ratio | 0.72 | 0.76 | 0.43 | 0.10 | 0.08 | 0.05 |
Debt / EBITDA Ratio | - | - | 5.00 | 0.32 | 0.23 | 0.07 |
Debt / FCF Ratio | 2.46 | 2.70 | - | 0.39 | 3.79 | 0.12 |
Net Debt / Equity Ratio | 0.61 | 0.60 | 0.34 | -0.10 | -0.02 | -0.20 |
Net Debt / EBITDA Ratio | -0.57 | -0.58 | 4.00 | -0.35 | -0.06 | -0.28 |
Net Debt / FCF Ratio | 2.09 | 2.12 | -1.94 | -0.42 | -1.10 | -0.53 |
Asset Turnover | 0.23 | 0.22 | 0.51 | 1.20 | 1.13 | 1.35 |
Inventory Turnover | 1.71 | 1.61 | 1.22 | 4.59 | 3.31 | 2.92 |
Quick Ratio | 2.43 | 1.12 | 1.01 | 1.85 | 1.76 | 1.45 |
Current Ratio | 3.14 | 1.53 | 2.19 | 2.35 | 2.37 | 2.09 |
Return on Equity (ROE) | -64.05% | -62.80% | 6.22% | 28.95% | 35.99% | 78.81% |
Return on Assets (ROA) | -27.85% | -25.87% | 2.78% | 13.04% | 15.98% | 32.93% |
Return on Invested Capital (ROIC) | -67.56% | -51.17% | 5.82% | 30.68% | 39.78% | 85.55% |
Return on Capital Employed (ROCE) | -72.30% | -88.90% | 7.00% | 28.60% | 35.10% | 65.60% |
Earnings Yield | -50.58% | -32.59% | 3.13% | 5.50% | 5.37% | 5.12% |
FCF Yield | 15.74% | 10.07% | -8.62% | 5.36% | 0.38% | 3.30% |
Dividend Yield | - | - | 0.76% | 1.36% | 0.60% | 0.51% |
Payout Ratio | - | - | 130.00% | 11.02% | 13.46% | 8.44% |
Buyback Yield / Dilution | 0.05% | 0.06% | 0.20% | 0.00% | 0.00% | 0.00% |
Total Shareholder Return | 0.05% | 0.06% | 0.96% | 1.36% | 0.60% | 0.51% |